Global Longlife Hospital and Research Ltd Share Price
As of 23 Sept 2026, Global Longlife Hospital and Research Ltd share price is ₹14.53. The stock opened at ₹14.53 and had closed at ₹14.82 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹9.00 and a high of ₹26.73. In terms of performance, Global Longlife Hospital and Research Ltd share price has decreased by 2.87% over the past six months and has decreased by 43.02% over the last year.
Global Longlife Stock Price Chart
Global Longlife Hospital and Research Ltd Overview
About Global Longlife
Global Longlife Hospital & Research is an Ahmedabad, Gujarat-based multi-speciality tertiary care hospital certified by the NABH (National Accreditation Board for Hospitals and Healthcare Providers). Founded in 2012, the healthcare provider offers a wide array of medical, surgical, and diagnostic services with a strong focus on oncology, cardiology, and other allied specialities.
Global Longlife Hospital and Research Ltd Historical Performance
Global Longlife Hospital and Research Ltd Fundamentals
Global Longlife Hospital and Research Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 0.01 | 5.60 | 13.57 | 23.74 | 33.05 |
| EBITDA | -0.99 | 0.86 | -0.25 | 4.28 | 8.25 |
| Net Profit | -1.72 | 0.20 | -2.19 | 1.83 | 3.57 |
| EPS | -1.64 | 0.19 | -2.08 | 1.79 | 5.11 |
Global Longlife Hospital and Research Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 14.18 |
| Resistance 1 (R1) | 15.38 |
| Pivot Point | 14.74 |
Global Longlife Hospital and Research Ltd Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Dhruv Sureshkumar Jani | Managing Director |
| Hetal Thakkar | Chief Financial Officer |
| Sucheta Dhruvkumar Jani | Non Executive Director |
Global Longlife Hospital and Research Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Apollo Hospitals Enterprise LtdAPOLLOHOSP | ₹8,835.50-0.86% | ₹1,10,231.07 | 59.08 | 20.48% |
| Max Healthcare Institute LtdMAXHEALTH | ₹1,056.50-0.95% | ₹1,02,534.79 | 72.27 | 13.42% |
| Fortis Healthcare LtdFORTIS | ₹896.55+0.34% | ₹68,746.49 | 70.10 | 10.53% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Global Longlife Hospital and Research Ltd today is ₹14.53 on NSE and ₹14.53 on BSE.
- The 52-week high of Global Longlife Hospital and Research Ltd is ₹26.73, while the 52-week low is ₹9.00.
- The current market capitalisation of Global Longlife Hospital and Research Ltd is approximately ₹15 crore.
- The P/E (Price-to-Earnings) ratio of Global Longlife Hospital and Research Ltd is -8.86. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Global Longlife Hospital and Research Ltd is 0.64. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Global Longlife Hospital and Research Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for Global Longlife on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Global Longlife Hospital and Research Ltd has delivered a return of approximately -67.71%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Global Longlife Hospital and Research Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 22.88% promoters, 0.00% FIIs, 0.00% DIIs, and 56.32% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
